• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Molecular biological analysis of signal transduction system through parathyroid hormone receptor. Evaluation of parathyroid hormone receptor in patients with pseudohypoparathyroidism.

Research Project

Project/Area Number 07671109
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field 内分泌・代謝学
Research InstitutionUniversity of Tokyo

Principal Investigator

FUKUMOTO Seiji  University of Tokyo, 4th Dept of Internal Med, Assistant Professor, 医学部・附属病院(分), 助手 (30202287)

Co-Investigator(Kenkyū-buntansha) TAKEUCHI Yasuhiro  University of Tokyo, 4th Dept of Internal Med, Assistant Professor, 医学部・附属病院(分), 助手 (50202164)
Project Period (FY) 1995 – 1996
Project Status Completed (Fiscal Year 1996)
Budget Amount *help
¥2,300,000 (Direct Cost: ¥2,300,000)
Fiscal Year 1996: ¥800,000 (Direct Cost: ¥800,000)
Fiscal Year 1995: ¥1,500,000 (Direct Cost: ¥1,500,000)
KeywordsPseudohypoparathyroidism / PTH receptor / Molecular biology
Research Abstract

Pseudohypoparathyroidism (PHP) is a group of diseases characterized by resistance to parathyroid hormone (PTH) and PHP1b has been thought to be caused by abnormal PTH receptor. In order to clarify the pathogenesis of PHP1b, PTH receptor in skin fibroblasts from patients with PHP1b was analyzed by reverse-transcription coupled polymerase chain reaction (RT-PCR), Northern blot analysis and direct sequencing of the PCR products. Although no mutation was found in cDNA for PTH receptor in patients with PHP1b, the expression level of PTH receptor in skin fibroblasts from patients with PHP1b was lower than that from normal control. Therefore, to clarify the mechanism of the reduced expression of PTH receptor in patients with PHP1b, we next cloned the 5' end of human PTH receptor gene. We found that there are at least two promoters and three untranslated exons in the 5' end of human PTH receptor gene, and these promoters and exons are used in a tissue-specific manner. However, the DNA sequences in these promoter regions and untranslated exons from patients with PHP1b are not different from those of normal control. Therefore, it seems necessary to analyze the nuclear proteins that interact with the promoter region of human PTH receptor to elucidate the pathogenesis of PHP1b.

Report

(3 results)
  • 1996 Annual Research Report   Final Research Report Summary
  • 1995 Annual Research Report
  • Research Products

    (17 results)

All Other

All Publications (17 results)

  • [Publications] Hata K et al.: "Assay of serum pyridinoline : A potential marker for bone resorption" Clin Chim Acta. 235. 221-227 (1995)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Martin T J et al.: "Some aspects of the anabolic action of parathyroid hormone" Miner Electrolyte Metab. 21. 87-90 (1995)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Heath JK et al.: "Epidermal growth factor stimulated parathyroid hormone-related protein expression involves increased gene transcription and mRNA stability" Biochem J. 307. 159-167 (1995)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Fukumoto S et al.: "Absence of mutations in parathyroid hormone (PTH) /PTH-related protein receptor cDNA in patients with pseudohypoparathyroidism type Ib" J Clin Endocrinol Metab. 81. 2554-2558 (1996)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Nakayama K et al.: "Differences in bone and vitamin D metabolism between primary hyperparathyroidism and malignancy-associated hypercalcemia" J Clin Endocrinol Metab. 81. 607-611 (1996)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Fuse H et al.: "A new synthetic steroid,TZP-4238,increases cortical bone mass and strength by enhancing bone formation in ovariectomized rats" J Bone Miner Res. (in press).

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Hata K et al.: "Assay of serum pyridinoline : A potential marker for bone resorption" Clin Chim Acta. 235. 221-227 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Martin TJ et al.: "Some aspects of the anabolic action of parathyroid hormone" Miner Electrolyte Metab. 21. 87-90 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Heath JK et al.: "Epidermal growth factor stimulated parathyroid hormone-related protein expression involves increased gene transcription and mRNA stability" Biochemical J. 307. 159-167 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Fukumoto S et al.: "Absence of mutations in parathyroid hormone (PTH)/PTH-related protein receptor cDNA in patients with pseudohypoparathyroidism type Ib" J Clin Endocrinol Metab. 81. 2554-2558 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Nakayama K et al.: "Differences in bone and vitamin D metabolism between primary hyperparathyroidism and malignancy-associated hypercalcemia" J Clin Endocrinol Metab. 81. 607-611 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Fuse H et al.: "A new synthetic steroid, TZP-4238, increases cortical bone mass and strength by enhancing bone formation in ovariectomized rats" J Bone Miner Res. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Fukumoto S et al.: "Absence of mutations in parathyroid hormone(PTH)/PTH-related protein receptor cDNA in patients with pseudohypoparathyroidism type Ib" Journal of Clinical Endocrinology and Metabolism. 81(7). 2554-2558 (1996)

    • Related Report
      1996 Annual Research Report
  • [Publications] Nakayama K et al.: "Differences in bone and vitamin D metabolism between primary hyperparathyroidism and malignancy-associated hypercalcemia" Journal of Clinical Endocrinology and Metabolism. 81(2). 607-611 (1996)

    • Related Report
      1996 Annual Research Report
  • [Publications] Fuse H et al.: "A new synthetic steroid,TZP-4238,increases cortical bone mass and strength by enhancing bone formation in ovariectomized rats" Journal of Bone and Mineral Research. (in press). (1997)

    • Related Report
      1996 Annual Research Report
  • [Publications] Martin TJ et al.: "Some aspccts of the anabolic action of parathyroid hormonc." Miner Electrolyte Mctab. 21. 87-90 (1995)

    • Related Report
      1995 Annual Research Report
  • [Publications] Heath JK et al.: "Epidermal growth factor stimulated parathyroid hormone-related protein expression involves increased gene transcription and mRNA stability." Biochem J.307. 159-167 (1995)

    • Related Report
      1995 Annual Research Report

URL: 

Published: 1995-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi